Skip to content
Open access

Evaluation of characteristics and outcomes of head and neck squamous cell carcinoma in post-transplant patients.

Oct 2026 · JCO Oncology Practice · Vol 22, pp. 669-669 · 0 citations

TL;DR

In a cohort of 5,815 transplant patients, most cases of post-transplant HNSCC were localized cSCC managed with surgery alone, reinforcing the value of annual skin exam screenings in SOTRs.

Abstract

669 Background: While it is well established that solid organ transplant recipients (SOTRs) are at increased risk for post-transplant related malignancy, there is a paucity of literature examining the outcomes of patients who develop post-transplant head and neck squamous cell carcinoma (HNSCC) with limited studies showing SOTRs presenting with more aggressive patterns of HNSCC, higher risk of disease recurrence, and decreased survival. Multiple society guidelines recommend an annual skin exam to screen for cutaneous cancers. However, there is no strong recommendation for screening of HNSCC. The goal of our study was to examine clinical trajectories in those who develop post-transplant HNSCC, to help inform screening practices, prognostic counseling, and treatment strategies. Methods: We performed a single institution retrospective study to investigate characteristics and outcomes in SOTRs who develop HNSCC. We identified patients who developed HNSCC after solid organ transplant treated at the University of Chicago Medical Center from 2010-2025 using automated tools in the electronic medical record. Results: Out of a cohort of 5,815 transplant patients, we identified 105 SOTRs who developed cancer in the head and neck region. Of these patients, 67 (63.8%) had cutaneous SCC (cSCC) requiring surgery alone. 38 (36.2%) developed HNSCC requiring systemic therapy and were included in our analysis. 29.0% were heart transplant recipients, 34.2% kidney, 13.2% liver, 7.9% lung, and 15.8% multi-organ. The mean time from transplant to diagnosis of HNSCC was 11 years (SD 9.4, median 8, range 4 months-34 years). 42.1% of patients reported light to heavy tobacco use. 18.4% of tumors were HPV-positive. The primary site of cancer was 50% cutaneous, 18.4% oral cavity, and 31.6% oropharynx. 10.5% of patients had distant disease at the time of diagnosis. For initial treatment, 26.3% received chemoradiation, 55.3% received surgery with neoadjuvant and/or adjuvant treatment, and 18.4% received systemic treatment alone. 47.4% had a documented recurrence after initial treatment (78% local recurrence and 22% distant recurrence). The mean time to recurrence was 1.74 years (SD 3.0, median 0.96). Conclusions: In our cohort, most cases of post-transplant HNSCC were localized cSCC managed with surgery alone, reinforcing the value of annual skin exam screenings in SOTRs. Although the incidence of HNSCC requiring systemic therapy was overall infrequent, SOTRs can develop HNSCC many years after transplant. Despite aggressive treatment, those who develop HNSCC face a substantial risk of recurrent disease, emphasizing the need for long-term surveillance after transplantation and close follow-up after cancer treatment. Given that a significant proportion of patients were tobacco users, patient education on the risk of HNSCC and symptom recognition for early disease detection may be of value in high-risk SOTRs.

Read PDF

Similar papers

Open access Sep 2026

Recipient and Donor Factors Impacting Head and Neck Squamous Cell Carcinoma Risk After Transplant.

OBJECTIVE Solid organ transplant (SOT) recipients carry an increased risk of head and neck squamous cell carcinoma (HNSCC); however, the specific factors that modulate this risk remain incompletely characterized. This study evaluates recipient and donor characteristics associated with HNSCC in a national transplant reg...

Adrienne Biskaduros, Aasiya Islam, Chinedu Odedo et al. · 0 citations
Oct 2026

Clinical characteristics, treatment patterns, and oncological outcomes in patients with squamous cell carcinoma of the head and neck at very advanced age (≥80 years).

INTRODUCTION Population aging has increased the number of patients with head and neck squamous cell carcinoma (HNSCC) who are very elderly (≥80 years). However, patients ≥80 years remain poorly characterized, and their clinical profile and prognosis continue to be a subject of debate. The objective of this study is to...

Leyre Pérez-Ugarte, Anna Holgado, Cristina Vázquez-López et al. · 0 citations
Review Open access Sep 2026

Survival analysis in patients with laryngeal cancer.A retrospective cohort study at Ocean Road Cancer Institute

Background: Laryngeal cancer (LC) represents the most common head and neck squamous cell carcinoma in Tanzania. Although global trends demonstrate declining incidence and improving outcomes, survival disparities remain substantial, largely driven by inequities in access to definitive surgical care and the increasing ad...

E. Lugina, A. Mrema, Nazima Dharsee et al. · 0 citations
Open access Sep 2026

Clinicopathological features and associated risk factors of oral cancer in a high-risk population

Oral squamous cell carcinoma (OSCC) is a leading cause of mortality among head and neck cancers. Despite extensive research efforts, the interplay of demographic, socioeconomic, and behavioral risk factors in high-risk populations is not yet fully understood. This study aimed to comprehensively investigate the clinicop...

F. Musaie, H. Rezaei, Z. Pourtaghi et al. · 0 citations
Open access Sep 2026

The clinicopathologic and molecular profile of second primary thyroid cancer in pediatric cancer survivors

To characterize the clinicopathological and molecular profiles, treatment, and outcomes of second primary thyroid cancer (SPTC) in childhood cancer survivors to inform risk-stratified surveillance and management. This retrospective case series enrolled patients (aged ≤18 years at thyroid cancer diagnosis)...

Yu-Wei Liu, Ai-Lei Yang, Yan-Zhen Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.